Dissecting liver tumor heterogeneity to improve health equity-Reference-Cited by-同舟云学术

Dissecting liver tumor heterogeneity to improve health equity

Published:2022-04 Issue:4 Volume:8 Page:286-290
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Ma Lichun,Wang Xin Wei^ORCID

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia;Shin;Asian Pac. J. Cancer Prev.,2010

2. Epidemiology and surveillance for hepatocellular carcinoma: new trends;Singal;J. Hepatol.,2020

3. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer;Ma;Cancer Cell,2019

4. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma;Ma;J. Hepatol.,2021

5. Comprehensive and integrative genomic characterization of hepatocellular carcinoma;The Cancer Genome Atlas Research Network;Cell,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer;Molecular and Cellular Biochemistry;2024-03-22

2. Tracking Down the Origins of a Divergent Subtype of Liver Cancer in Indigenous Americans in Peru;Indigenous and Tribal Peoples and Cancer;2024

3. Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases;eGastroenterology;2023-10

4. Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?;Cancer Research;2023-09-25